NEU 0.15% $13.13 neuren pharmaceuticals limited

Share Price, page-5796

  1. 2,649 Posts.
    lightbulb Created with Sketch. 427
    Great news.

    It’s great for Neuren and I also think it’s fantastic for Retts sufferers in those regions. Acadia has proven to be a really good partner, and seemingly caring organization to the patient communities - Acadia, although they don’t have a presence outside the US, must view Daybue as their opportunity for expansion - they are obviously extremely pleased with the take up in the states and it also gives them the best chance to ensure the price for the drug won’t be seriously undercut.

    Speed to market won’t be compromised from this in my view.
    Last edited by good1234: 14/07/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.